Pediatric critical care remains a pivotal frontier in modern medicine, confronting unique challenges shaped by the dynamic physiology and developmental ...

Adrenomed’s goal is to fill the gap in patient treatment further downstream of inflammation with Adrecizumab, the first sepsis therapy candidate to target an important causal pathophysiology of ...

One night he was looking after a baby boy who had sepsis, which is where the immune ... It feels like we're discovering ...

Sepsis is one of the most common life-threatening conditions in intensive care units, with approximately 48.9 million cases reported worldwide in 2017, accounting for 19.7% of total global mortality.